UROGENITAL SYSTEM AND HORMONAL EFFECTS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Childhood obesity reshapes physiology across multiple axes beyond excess weight, including metabolism and the urogenital system. Adipose tissue functions as an endocrine organ: altered adipokines (e.g., leptin, adiponectin), chronic low-grade inflammation, and insulin resistance/hyperinsulinemia interacting with the hypothalamic-pituitary-gonadal (HPG) axis. Hyperinsulinemia suppresses sex hormone–binding globulin (SHBG) and augments steroidogenesis; increased aromatase activity raises peripheral estrogen exposure; neuroendocrine signaling (GnRH/LH) may be perturbed. Clinically, these inputs modify both pubertal timing and tempo; in girls, they increase the risk of earlier thelarche/menarche and polycystic ovary syndrome (PCOS). In boys, effects on puberty are heterogeneous and can also culminate in a largely reversible form of functional hypogonadism characterized by reduced bioavailable testosterone. Urogenital consequences include an increased incidence of urinary tract infection, nocturnal enuresis, and mucocutaneous/genital infections (e.g., intertrigo, candidiasis, balanitis/vulvovaginitis), as well as buried penis, and—among those with severe obesity—early indicators of renal injury, such as hyperfiltration and albuminuria. Evaluation should proceed with awareness of these effects and attention to pubertal tempo and assay methodology. In adolescents, diagnosis of PCOS prioritizes persistent ovulatory dysfunction plus clinical/biochemical hyperandrogenism, while avoiding reliance on ovarian morphology in the early postmenarchal period. For boys, morning testosterone should be interpreted in conjunction with SHBG (and LH/FSH) measurements; imaging and semen analysis are reserved for selected cases. First-line treatment remains lifestyle modification. In true central precocious puberty, GnRH analog therapy may be considered. For PCOS, combined oral contraceptives, metformin, and antiandrogens should be individualized. Exogenous testosterone is generally contraindicated in adolescents with obesity-related functional hypogonadism. Screening for cardiometabolic risk, sleep disorders, dermatologic/urogenital complications, and mental health is integral to care. Optimal management requires multidisciplinary collaboration among pediatric endocrinology, primary care, nutrition/dietetics, psychology, sleep medicine, dermatology, urology/gynecology, and—when needed—nephrology. Sustained weight reduction remains the most effective disease-modifying strategy.
Fields of Study & Subjects
Hypothalamic control of reproductive hormones
Ovarian function and disorders
Hormonal and reproductive studies
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 163–176
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter